title: Cancer of unknown primary finally revealed to be a metastatic prostate cancer: a case report.
abstract: The vast majority of patients with metastatic prostate cancer present with bone metastases and high prostate specific antigen (PSA) level. Rarely, prostate cancer can develop in patients with normal PSA level. Here, we report a patient who presented with a periureteral tumor of unknown primary site that was confirmed as prostate adenocarcinoma after three years with using specific immunohistochemical examination. A 64-year old man was admitted to our hospital with left flank pain associated with masses on the left pelvic cavity with left hydronephrosis. All tumor markers including CEA, CA19-9, and PSA were within the normal range. After an exploratory mass excision and left nephrectomy, the pelvic mass was diagnosed as poorly differentiated carcinoma without specific positive immunohistochemical markers. At that time, we treated him as having a cancer of unknown primary site. After approximately three years later, he revisited the hospital with a complaint of right shoulder pain. A right scapular mass was newly detected with a high serum PSA level (101.7 ng/ml). Tissues from the scapular mass and prostate revealed prostate cancer with positive immunoreactivity for P504S, a new prostate cancer-specific gene. The histological findings were the same as the previous pelvic mass; however, positive staining for PSA was observed only in the prostate mass. This case demonstrates a patient with prostate cancer and negative serological test and tissue staining that turned out to be positive during progression. We suggest the usefulness of newly developed immunohistochemical markers such as P504S to determine the specific primary site of metastatic poorly differentiated adenocarcinoma in men.
authors.affiliation: Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul, Korea.
authors.forename: Jung Yeon
authors.initials: JY
authors.lastname: Cho
authors.forename: Eun Jin
authors.initials: EJ
authors.lastname: Shim
authors.forename: In Seon
authors.initials: IS
authors.lastname: Kim
authors.forename: Eun Mi
authors.initials: EM
authors.lastname: Nam
authors.forename: Moon Young
authors.initials: MY
authors.lastname: Choi
authors.forename: Kyung Eun
authors.initials: KE
authors.lastname: Lee
authors.forename: Yeung Chul
authors.initials: YC
authors.lastname: Mun
authors.forename: Chu Myoung
authors.initials: CM
authors.lastname: Seoung
authors.forename: Soon Nam
authors.initials: SN
authors.lastname: Lee
authors.forename: Dong Eun
authors.initials: DE
authors.lastname: Song
authors.forename: Woon Sup
authors.initials: WS
authors.lastname: Han
references.citation: Cancer. 2004 May 1;100(9):1776-85
references.pmid: 15112256
references.citation: JAMA. 2002 Apr 3;287(13):1662-70
references.pmid: 11926890
references.citation: Am J Clin Pathol. 2002 Mar;117(3):471-7
references.pmid: 11888088
references.citation: Cancer Res. 2000 Mar 15;60(6):1677-82
references.pmid: 10749139
references.citation: N Engl J Med. 2004 May 27;350(22):2239-46
references.pmid: 15163773
references.citation: Am J Surg Pathol. 2007 Sep;31(9):1351-5
references.pmid: 17721190
references.citation: J Urol. 1999 Aug;162(2):293-306
references.pmid: 10411025
references.citation: Am J Surg Pathol. 2007 Aug;31(8):1246-55
references.pmid: 17667550
references.citation: Eur J Cancer. 2003 Sep;39(14):1990-2005
references.pmid: 12957453
references.citation: Am J Surg Pathol. 2002 Dec;26(12):1588-96
references.pmid: 12459625
references.citation: Int J Surg Pathol. 2007 Apr;15(2):213-8
references.pmid: 17478786
references.citation: Am J Surg Pathol. 2001 Nov;25(11):1397-404
references.pmid: 11684956